Pharma News India

The Indian pharmaceutical industry is growing at a very fast pace. With its fast growth, it is highly imperative to stay updated with the current news and trends in the market. Brand India Pharma gives you the latest pharmacy related news to help you stay updated. Read the latest pharmaceutical news about different sectors and their strategies in the Indian Pharma News section. Get fresh updates from Pharma companies like Natco, Panacea Biotec, Hamsons.
You can bookmark the Indian Pharma News section for the news on pharmaceuticals, drugs and formulations. The Brand India pharmacy news also includes pharmaceutical conference highlights for inquisitive readers.

The plant is expected to go on stream by the end of the year.

New Delhi, April 7, 2015: Mankind Pharma is planning to invest close to Rs100 crore in setting up active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on stream by the end of the year.


The company has launched its Amlodipine and Valsartan tablets in the US market.

New Delhi, April 1, 2015: Lupin has launched its Amlodipine and Valsartan tablets, used for the treatment of hypertension, in the US market. The company said in a statement that its US arm, Lupin Pharmaceuticals Inc has launched Amlodipine and Valsartan in various strengths in the US market after sec...


The company is in talks to raise US$ 75-100 million.

Hyderabad, March 27, 2015: The Indian pharmacy chain MedPlus is in preliminary talks to raise US$ 75-100 million to develop its warehousing and supply chain infrastructure to serve new geographies. The company aims to expand its operations to around 50 cities via a mixed strategy of franchisee and company owned stores. The com...


The patents have been granted in Canada, Japan and Korea.

New Delhi, March 24, 2015: The Drug firm Suven Life Sciences has received patents each by Canada, Japan and Korea for molecules, aims to be developed as drugs, for the treatment of neuro-degenerative diseases.


The move is in line with the niche foray strategy of Sun Pharma.

Mumbai, March 5, 2015: Sun Pharmaceutical Industries has acquired the opiates business of GlaxoSmithKline (GSK) in Australia. The move is in line with the strategy to enter areas where the competition is limited.


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...